Journal
STEM CELL REVIEWS AND REPORTS
Volume 17, Issue 4, Pages 1194-1214Publisher
SPRINGER
DOI: 10.1007/s12015-020-10086-7
Keywords
Trauma; Cell therapy
Funding
- US Army Medical Research and Development Command, Combat Casualty Care Research Program
- Internal Medicine Residency Research & Scholarly Activity Curriculum Individualized Research Elective program
Ask authors/readers for more resources
Traumatic injuries are a major cause of death and disability, requiring novel and personalized treatment strategies for optimal outcomes. Cellular therapies have shown potential in treating acute or chronic injuries, with various cell-based pharmaceuticals currently under preclinical studies or clinical trials. These therapies may complement existing treatments by restoring lost organ function due to tissue disruption, prolonged hypoxia, or inflammatory damage.
Traumatic injuries are a leading cause of death and disability in both military and civilian populations. Given the complexity and diversity of traumatic injuries, novel and individualized treatment strategies are required to optimize outcomes. Cellular therapies have potential benefit for the treatment of acute or chronic injuries, and various cell-based pharmaceuticals are currently being tested in preclinical studies or in clinical trials. Cellular therapeutics may have the ability to complement existing therapies, especially in restoring organ function lost due to tissue disruption, prolonged hypoxia or inflammatory damage. In this article we highlight the current status and discuss future directions of cellular therapies for the treatment of traumatic injury. Both published research and ongoing clinical trials are discussed here.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available